Chikungunya Vaccine (V184) Study in Previously Exposed Adults (V184-006)

Clinical trial NCT03807843 · COMPLETED

Trial details

NCT number: NCT03807843
Sponsor: Themis Bioscience GmbH
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chikungunya Virus Infection

Start date: 2019-07-16
Primary completion: 2021-05-13
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.